REFERENCES
- Kupper N, Ge D, Treiber FA, Snieder H. Emergence of novel genetic effects on blood pressure and hemodynamics in adolescence. The Georgia Cardiovascular Twin Study. Hypertension 2006; 47:948.
- Leeb-Lundberg LMF, Marceau F, Muller-Esterl W, Pettibone JD, Zuraw LB. International Union of Pharmacology. XIV. Classification of kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 2005; 57:27–77.
- Mattson DL, Cowley AW Jr. Kinin actions on renal papillary blood flow and sodium excretion. Hypertension 1993; 21(6 Pt 2):961–965.
- Linz W, Wiemer G, Schölkens BA. Cardioprotective actions of bradykinin in myocardial ischemia and left ventricular hypertrophy. Braz J Med Biol Res 1994; 27(8):1949–1954.
- Katori M, Majima M. A missing link between a high salt intake and blood pressure increase. J Pharmacol Sci 2006; 100(5):370–390.
- Sharma JN. Hypertension and the bradykinin system. Curr Hypertens Rep 2009; 11:178–181.
- Mukae S, Aoki S, Itoh S, . Promoter polymorphism of Beta2 bradykinin receptor gene in association with essential hypertension. Jpn Circ J 1999; 63:759–762.
- Dhamrait SS, Payne JR, Li P, . Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension. Eur Heart J 2003; 24(18):1672–1680.
- Fu Y, Katsuya T, Matsuo A, . Relationship of bradykinin B2 receptor gene polymorphism with essential hypertension and left ventricular hypertrophy. Hypertens Res 2004; 27(12):933–938.
- Niu W, Qi Y, Gao P, Zhu D. A meta-analysis of the bradykinin B2 receptor gene −58C/T polymorphism with hypertension. Clin Chim Acta 2010; 411:1873–3492.
- Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980; 32:1–46.
- Wang DZ, Chao L, Chao J. Hypotension in transgenic mice overexpressing human bradykinin B2 receptor. Hypertension 1997; 29:488–493.
- Braun A, Kammerer S, Bohme E, Muller B, Roscher AA. Identification of polymorphic sites of the human bradykinin B2 receptor gene. Biochem Biophys Res Commun 1995; 211:234–240.
- Braun A, Kammerer S, Maier E, Böhme E, Roscher AA. Polymorphism in the gene for the human B2-bradykinin receptor: new tools assessing a genetic risk for bradykinin-associated disease. Immunopharmacology 1996; 33:32–35.
- Kammerer S, Braun A, Arnold N, Roscher AA. The human bradykinin B2 receptor gene: full length cDNA, genomic organization and identification of the regulatory region. Biochem Biophys Res Commun 1995; 211:226–233.
- Shuji M, Aoki S, Itoh S, . Promoter polymorphism of Beta2 bradykinin receptor gene in association with essential hypertension. Jpn Circ J 1999; 63:759–762.
- Lahiri DK, Nurnberger JRJI. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19:5444.
- Qi Y, Niu W, Zhu T, Zhou W, Qiu C. Synergistic effect of the genetic polymorphisms of the renin-angiotensin-aldosterone system on high-altitude pulmonary edema: a study from Qinghai-Tibet altitude. Eur J Epidemiol 2008; 23(2):143–152.
- Moore JH, Gilbert JC, Tsai CT, . A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol 2006; 241(2):252–261.
- Gainer JV, Brown NJ, Bachvarova M, . Altered frequency of a promoter polymorphism of the kinin B2 receptor gene in hypertensive Afro-Americans. Am J Hypertens 2000; 13:1268–1273.
- Aoki S, Mukae S, Itoh S, . The genetic factor in acute myocardial infarction with hypertension. Jpn Circ J 2001; 65:621–626.
- Linz W, Wiemer G, Gohlke P, Unger T, Scholkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 1995; 47:25–49.
- Wang B, Dang A, Liu G. Genetic variation in the promoter region of the beta2 bradykinin receptor gene is associated with essential hypertension in a Chinese Han population. Hypertens Res 2001; 24(3):299–302.
- Freitas SR, Pereira AC, Floriano MS, Mill JG, Krieger JE. Insertion/deletion polymorphism of the bradykinin type 2 receptor gene influence diastolic blood pressure. J Hum Hypertens 2009; 23:553–555.
- Brull D, Dhamrait S, Myerson S, . Bradykinin B2BKR receptor polymorphism and left-ventricular growth response. Lancet 2001; 358(9288):1155–1156.
- Lung CC, Chan EK, Zuraw BL. Analysis of an exon 1 polymorphism of the B2 bradykinin receptor gene and its transcript in normal subjects and patients with C1 inhibitor deficiency. L Allergy Clin Immunol 1997; 99:134–146.